Opportunity:

We are living through a Fourth Industrial Revolution marked by rapid technological change and the convergence of physical, digital, and biological systems. Advances in the life sciences have the potential to transform human health, strengthen economic resilience, and create a more sustainable future.

The Challenge:

Yet at the very moment when scientific innovation is accelerating, early-stage life science research faces a growing funding crisis.

Federal funding pressures, shifting investment priorities, and increasingly risk-averse capital markets have created a widening gap between discovery and commercialization. Transformational ideas emerging from universities, research institutions, and startups often lack the resources needed to generate the proof-of-concept data required to attract venture investment. As a result, promising breakthroughs remain stranded, weakening America's long-term competitiveness and innovation pipeline.

A New Source of Capital

This challenge coincides with a historic rise in private wealth and philanthropic capital. Over the past five years, the number of single-family offices has grown by more than 30% to over 8,000 worldwide and is projected to exceed 10,000 by 2030, stewarding an estimated $9.5 trillion in assets. Alongside foundations, venture philanthropists, patient advocates, and mission-driven investors, these institutions represent an unprecedented source of long-term capital.

However, many family office/ philanthropic investors lack the expertise, networks, and infrastructure needed to confidently support early-stage life science research, where scientific complexity and development risk remain significant barriers.

The Solution: Connector Hubs

Connector Hubs is a new initiative designed to bridge this gap by building regional ecosystems that connect capital, talent, science, and industry around breakthrough discoveries.

The initiative mobilizes four forms of capital:

• Financial – Family offices, philanthropic foundations, patient communities, and mission-aligned investors.
• Scientific – Researchers, universities, academic medical centers, and scientific innovators.
• Human – Entrepreneurs, venture studios, translational experts, and startup leaders.
• Industry – Biotechnology companies, strategic partners, and commercialization pathways.

By aligning these resources within collaborative regional networks, Connector Hubs helps identify promising discoveries, accelerate translational research, launch sustainable startups, and unlock new pathways for impact investment.

Result

Connector Hubs creates a new model for advancing life science innovation, one that channels private capital toward breakthrough research, strengthens regional innovation. This accelerates the translation of discovery into impact, and helps rebuild U.S. leadership across science, technology, and biotechnology. The result is a more resilient, and effective innovation ecosystem capable of turning today's scientific discoveries into tomorrow's solutions.